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1. Abstract 
Fusarium mycotoxins such as trichothecenes, zearalenone and fumonisins occur on a 
worldwide basis in cereal grains, animal feeds and forages. Practical solutions for multiple 
mycotoxin determination in samples are required by industry and regulators for cost effective 
screening purposes. The feasibility of developing a novel multiplex nanoarray for the 
simultaneous and semi-quantitative detection of three regulated mycotoxins: zearalenone 
(ZEA), T2-toxin (T2) and fumonisin B1 (FUM) was examined. Additionally, the assay was 
also able to detect HT2 toxin and fumonisin B2 and B3 due to the cross reactivity profiles of 
the antibodies used. Individual mycotoxin conjugates specific to the three mycotoxins were 
nano-spotted onto wells of a microtitre plate. Optimisation of assay parameters and antibodies 
was undertaken with both individual and multiplex calibration curves generated. A competitive 
assay format was employed enabling a calibration curve for concentration analysis and 
duplicate results for up to 40 samples in 70 min for the three target mycotoxins. The 
characteristics and performance of the nanoarray were evaluated including sensitivity and 
specificity for each target. Additionally, intra and inter spotting precision, cross reactivity, 
matrix effects and sample analysis in maize and wheat (n=8) was performed. Sensitivity, 
determined as the concentration causing 50 % inhibition, was 70.1, 2.8 and 90.9 ppb in PBS, 
172.4, 3.2 and 129.3 ppb in methanol, 197.4, 0.7 and 216.7 ppb in wheat and 43.6, 0.5 and 25.9 
ppb in maize for ZEA, T2 and FUM respectively. Intra spotting precision was 6, 11 and 10 % 
for PBS and 5, 11 and 12 % for methanol for ZEA, T2 and FUM respectively. Inter spotting 
precision was 4, 14 and 6 % for PBS and 3, 9 and 16 % for methanol for ZEA, T2 and FUM 
respectively. The feasibility of the nanoarray as an easy to use sensitive screening tool in the 
96 well format has been demonstrated for the multiplex detection of three regulated 
mycotoxins. Improvements in automated image and data analysis software for novice end users 
are required to improve the overall rapidity of analysis.  
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2. Introduction 
Mycotoxins are naturally occurring secondary chemical metabolites produced by different 
fungi genera such as Aspergillus, Fusarium, Penicillium, Alternaria and Claviceps [1]. Among 
these genera, Fusarium fungi are the most widespread in cereal crop production. Fusarium 
fungi produce a diversity of mycotoxin types and can have widespread geographical 
distribution influenced primarily by environmental and climatic conditions and crop 
production, storage, processing and transportation methods. Toxins produced by Fusarium 
moulds, include fumonisins, trichothecenes (deoxynivalenol, T2 and HT2 toxin) and 
zearalenone. Mycotoxins are chemically and thermally stable whereby mycotoxin 
contamination of raw materials may also affect processed foods [2]. Furthermore they can enter 
the food chain through animals fed contaminated feed [3]. Mycotoxin contamination is 
inhomogeneous in nature and the toxins can be present at very low levels. Due to their highly 
resistant nature they can remain in the food chain [4] thereby posing a threat as toxic 
contaminants of food products.  
The complex toxic effects of mycotoxins pose significant health risks to humans and animals 
and this necessitates for effective control and surveillance procedures [5-9]. The initial stages 
in the protection against mycotoxin contamination is through the adoption of good agricultural, 
storage and processing practices to ensure mycotoxin levels remain negligible or as low as 
reasonably achievable [10]. In order to protect consumer safety, legislative limits for 
mycotoxins in certain foodstuffs are set out by the European Commission [11-14].  
Contamination of food by these natural toxins is of an increasing safety and economic concern 
due to changes in prevalence with variations in environmental conditions. Therefore, 
innovation in the development of detection methods for implementation is vitally important. 
The detection of mycotoxins is carried out by confirmatory methods for quantitative analysis 
and by rapid diagnostics for screening. Several validated methods are available for the 
measurement of mycotoxins and the literature on this subject has included many 
comprehensive and critical reviews [8, 15-19]. For the quantitative analysis of mycotoxins high 
performance liquid chromatography (HPLC), gas chromatography (GC) and thin layer 
chromatography (TLC) as well as multiple toxin mass spectrometry (MS) methods are used 
[20-24]. These methods, however, require the use of complex and expensive equipment as well 
as skilled operators and extensive sample pre-treatment. Furthermore, these methods 
sometimes may not reach the very low limit of detection required. Immunoassays are often 
employed for the screening of mycotoxin contamination as they provide rapid, sensitive 
detection and easy to use methods. Immunological methods such as enzyme linked 
immunosorbent assay (ELISA) [25-29] and lateral flow devices (LFD) [30-33] are the most 
common approaches. These detection methods are simpler in design, inexpensive, fast, robust, 
user friendly and cost effective allowing high sample throughput with high sensitivity and 
accuracy. LFDs provide a ‘yes/no’ answer, however, in recent years modified devices enabling 
quantitative evaluation and multiplexing have been developed. In the Conffidence project 
funded by the European Union, a LFD enabling the simultaneous detection of Fusarium toxins 
(deoxynivalenol, zearalenone, T2/HT2 toxins, fumonisins) in cereals was developed [34] and 
now commercialised by Unisensor (Belgium). Commercial detection tests based on both 
ELISA and LFDs are also available for many of the mycotoxins from Tecna (Italy), R-
Biopharm (Germany), Europroxima (The Netherlands), Neogen (USA), Charm Sciences 
(USA), Diachemix (USA), Envirologix (USA), Romer Labs (USA) and Vicam (USA) but are 
all based on single toxin analysis for these mycotoxins. Randox (Crumlin, UK) offer a 
commercial test for multiple mycotoxin detection based on a customised biochip with 
chemiluminescent detection using relatively expensive closed technology. 
In addition to safety issues, natural toxin contamination of food is of great economic concern; 
much effort is therefore devoted to the development of novel, rapid, inexpensive, simple and 
sensitive multiple mycotoxin screening methods. The simultaneous identification of several 
mycotoxins in one single test, reducing time and costs per analysis is a most attractive option.  
Nanoarrays are important tools for high throughput analysis enabling miniaturization, higher 
sensitivity and simplified sample preparation and offer a number of applications in the areas of 
medical diagnosis, genetic testing, environmental monitoring and food safety. In recent years 
the nanoarray format has provided a powerful tool in which several targets are separately 
detected in spatially defined zones simultaneously. Oswald et al. (2013) described a multiple 
mycotoxin immunoassay using the Munich chip reader 3 platform and reusable biochips. A 
number of mycotoxins including aflatoxin, ochratoxin A, FUM and DON were spotted onto 
glass slides and detected in cereals using chemiluminescence [35]. Additionally, Beizaei et al. 
(2015) reported a rapid and highly sensitive microarray method for aflatoxin B1 detection in 
cereals using 16-pad nitrocellulose coated FAST slides [36]. The application of 
nanotechnology faces many challenges in order to produce successful commercial products 
that can compete with the traditional methods of mycotoxin analysis. In this study, it is intended 
to introduce the concept and advantages of nanotechnology to the food industry and describe 
the proof of concept and feasibility of a nanoarray for the simultaneous detection of three 
harmful mycotoxins. There are very few studies that effectively employ this promising 
technology for the detection of mycotoxins. Innovative nano science and technology with state 
of the art sensing equipment have allowed novel detection methods to become a reality. The 
aim of this research was therefore to develop a multiplex nanoarray for the simultaneous 
detection of three regulated Fusarium mycotoxins offering high throughput in the 96 well plate 
format compared to LFD platforms.  
 
3. Materials and methods 
3.1. Instrumentation 
A sciFLEXARRAYER S5 (Scienion, Germany) was used for spotting microtitre plates and a 
sciReader CL colorimetric nanoarray reader (Scienion, Germany) was used for scanning and 
analysing spot intensities. 
 
3.2. Reagents 
Antibodies for ZEA, T2 and FUM and mycotoxin-BSA conjugates for ZEA (3.39 mg/ml), T2 
(1.5 mg/ml) and FUM (1.32 mg/ml) were provided by Tecna (Tecna s.r.l, Trieste, Italy). Nunc 
96 well microtitre plates were purchased from VWR (Leicestershire, UK). Alkaline 
phosphatase substrate was purchased from Millipore (Hertfordshire, UK). Bovine serum 
albumin (BSA), anti-rabbit IgG-alkaline phosphatase antibody produced in goat, 5-bromo-4-
chloro-3'-indolyphosphate (BCIP), nitro-blue tetrazolium (NBT), methanol (HPLC grade), 
zearalenone, deoxynivalenol and HT2-toxin were all purchased from Sigma-Aldrich (Dorset, 
UK). Fumonisin B1 was purchased from Trilogy (Darmstadt, Germany). T2-toxin, fumonisin 
B2 and fumonisin B3 were purchased from Romer Labs (Cheshire, UK). 
 
3.3. Printing nanoarrays 
BSA-conjugated mycotoxins were diluted in filtered printing buffer (100 mM sodium 
phosphate, 50 mM sodium chloride, 100 μg/ml BSA, 0.005 % Tween-20, pH 8.0) at 50 µg/ml. 
A spotting volume of 1000 pl for each reagent was spotted onto a 96 well microtitre plate using 
a sciFLEXARRAYER S5. For part one of the study (single spotting analysis) a nine spot matrix 
format (3x3 array) was arrayed with a 1000 µm spot to spot pitch composing of nine replicates 
of each target in separate wells. For part two of the study (multi spotting analysis) a 12 spot 
matrix format (4x3 array) was arrayed with a 750 µm spot to spot pitch composing of four 
replicates of each target (x 3 targets) in the same well. All spotting was carried out at room 
temperature and 65 % humidity. Microtitre plates were left at 65 % humidity for 1 hr on the 
nanospotter before being stored at 25 °C and 30 % humidity overnight in a humidity chamber 
(Deny, China). 
 
3.4. Assay protocol 
The microtitre plate was blocked with 0.2 % BSA (100 µl) for 60 min at room temperature 
followed by 3 washes with ELISA wash solution (0.15 M NaCl, 0.0125 % Tween) and dried 
on lint free paper. Antibody (50 µl) diluted in PBS (0.1 M, pH 7.2) and sample/standard (50 
µl) diluted in PBS (0.1 M, pH 7.2) were applied to each well and incubated for 40 min at room 
temperature. The microtitre plate was washed 3 times with ELISA wash solution and dried 
with lint free paper. Alkaline phosphatase anti-rabbit IgG (100 µl) diluted 1/500 in PBS (0.1 
M, pH 7.2) was added to each well and incubated for 20 min at room temperature. The 
microtitre plate was washed 3 times with ELISA wash solution and dried with lint free paper. 
BCIP/NBT substrate (100 µl) was added to each well and incubated for 10 min at room 
temperature. Finally, the microtitre plate was washed 3 times with ELISA wash solution and 
dried with lint free paper.  
 
3.5. Image and data processing 
Microtitre plates were scanned using the sciReader colorimetric nanoarray reader at an 
exposure of 100 ms. An image of each well of the microtitre plate was taken and saved as a 
TIFF file. One microtitre plates takes approximately 1 min to scan. The images are opened and 
processed using sciANA software from Scienion. The spotting matrix of each well is defined 
by the number of blocks (1x1) and number of spots (4x3) so that the software knows the 
spotting configuration. Next the image is evaluated and the software attempts to find the 
spotting configuration that has been specified. If the software successfully detects the spots it 
will draw grids around each spot automatically. If the intensity between the spots and the 
background is similar the software will not be able to find the spots and instead the grids must 
be manually aligned by the user. Once grids are aligned the data can be exported into excel. 
The excel sheet will contain information on each spot of the well including for example X and 
Y coordinates, diameter, median intensity of spot and intensity of background. The median 
intensity (with background removed) measured in pixels is used for further data analysis. 
 
3.6. Optimisation  
A chequerboard design was employed to optimise the assay parameters. Microtitre plates were 
spotted in a single system (ZEA, T2 or FUM) to determine optimum parameters for each 
mycotoxin. Single antibodies to each mycotoxin were assessed. For ZEA microtitre plates were 
spotted at varying spotting volumes (330, 670, 1000, 2000 pl) at varying protein concentrations 
(0.5, 5 and 50 µg/ml) of the ZEA-BSA conjugate. For T2 and FUM a spotting volume of 1000 
pl at varying protein concentrations of 10, 50, 100 and 200 µg/ml of the mycotoxin-BSA 
conjugates were assessed. Two antibodies were compared for T2 (ABT-1 and ABT-2) and 
FUM (ABF-1 and ABF-2) while only one antibody was available for ZEA (ABZ). These were 
assessed at different dilutions ranging from 1/500 – 1/15,000. A negative and positive standard 
were assessed for each parameter to determine optimum spotting conditions for each 
mycotoxin. 
 
 
3.7. Individual calibration curves 
Microtitre plates were spotted in a single system (ZEA, T2 or FUM) to assess individual 
calibration curves for each mycotoxin. Spotting parameters and the assay parameters were 
determined during the optimisation stage. The microtitre plates were spotted using mycotoxin-
BSA conjugates at a spotting volume of 1000 pl and a protein concentration of 50 µg/ml for all 
three mycotoxin-BSA conjugates. Single antibodies for ZEA ABZ (1/10,000), T2-ABT-1 
(1/4000) T2-ABT-2 (1/4000), FUM-ABF-1 (1/4000) and FUM-ABF-2 (1/4000) were 
examined during the assay. Eight point calibration curves for ZEA, T2 or FUM were prepared 
in PBS (0.1 M, pH 7.2) and 23.3 % methanol (in water v/v) at concentrations across the full 
dynamic range for a full evaluation for individual mycotoxin analysis. The methanol curve 
(23.3%) was included throughout for comparison as the final extract in matrix (maize and 
wheat) was optimised providing 23.3% as the final percentage methanol in samples applied to 
the assay. Individual calibration curves were assessed and examined (n=2 analysis, 9 spots per 
analysis) and sensitivity was assessed using the 50 % inhibition concentration. The 50 % 
inhibition concentrations were determined from a 4 parameter fit curve using BIAevaluation 
version 4.1 software (Biacore, GE Healthcare). 
 
3.8. Multiplex calibration curves 
Microtitre plates were spotted in a three-plex system (ZEA, T2 and FUM) to assess multiplex 
calibration curves for each mycotoxin. Spotting and assay parameters were determined during 
the optimisation stage. Microtitre plates were spotted using mycotoxin-BSA conjugates at a 
spotting volume of 1000 pl and a protein concentration of 50 µg/ml for all three mycotoxin-
BSA conjugates. Antibodies for ZEA (ABZ 1/10,000), T2 (ABT-1 1/4000) and FUM (ABF-2 
1/4000) were examined during the assay. Eight point calibration curves for ZEA, T2 and FUM 
were prepared in PBS and methanol at concentrations across the full dynamic range for a full 
evaluation for individual mycotoxin analysis. Where necessary additional standards were 
added to improve the curve shape. Multiplex calibration curves were assessed and examined 
(n=6 analysis, 4 spots per analysis, 3 spotting days) and sensitivity was assessed using the 50 
% inhibition concentration. The 50 % inhibition concentrations were determined from a 4 
parameter fit curve using BIAevaluation version 4.1 software (Biacore, GE Healthcare). 
 
3.9. Cross reactivity 
Microtitre plates were spotted as described in section 3.7. Antibodies for ZEA (ABZ 1/10,000), 
T2 (ABT-1 1/4000) and FUM (ABF-2 1/4000) were examined during the assay for ZEA, T2, 
HT2, FUM B1, FUM B2, FUM B3, DON as individual calibration curves. Eight point 
calibration curves were prepared in methanol at concentrations across the full dynamic range 
for an evaluation of each mycotoxin. Where necessary additional standards were added to 
improve the curve shape so that the IC50 of the curve could be determined. Cross reactivity was 
determined from the following calculation whereby the main mycotoxin refers to ZEA, T2 and 
FUM B1. 
  % Cross reactivity = IC50 main mycotoxin / IC50 mycotoxin to be determined x 100  
 
3.10. Intra and inter spotting precision 
Microtitre plates were spotted as described in section 3.7. Antibodies for ZEA (ABZ 1/10,000), 
T2 (ABT-1 1/4000) and FUM (ABF-2 1/4000) were examined during the assay. Intra-spotting 
precision (n=96) was examined by analysing the mean intensity, of the maximum antibody 
binding achieved, on application of the 0 ppb standard in all 96 wells of the microtitre plate 
prepared using both PBS and methanol. Inter-spotting precision was assessed and examined 
over three separate spotting days.  The mean intensity, of the maximum antibody binding 
achieved on application of the 0 ppb standard, from all 96 wells was calculated and compared 
over the three different spotting days. Intra and inter spotting precision was determined from 
the coefficient of variation (% CV). 
 
Intra-spotting precision:  
% CV = Standard deviation (calculated from the intensity of 0 ppb) from 96 wells of one 
microtitre plate / Mean intensity of 0 ppb from 96 wells of one microtitre plate x 100 
 
Inter-spotting precision:  
% CV = Standard deviation (calculated from the mean intensity of the 0 ppb from 96 wells) of 
three microtitre plates / Mean intensity of 0 ppb from 96 wells of three microtitre plates x 100 
 
3.11. Sample preparation 
Blank and naturally incurred ground maize and wheat samples (2.5 g ± 0.02 g) were weighed 
into plastic centrifuge tubes. Methanol/deionised water (70/30, v/v, 12.5 ml) was added and 
the samples were mixed for 3 min using a roller mixer. Samples were filtered (Whatman 1 filter 
paper) and the extracts were diluted 1 in3 in deionised water to give a final percentage of 
methanol at 23.3 % (v/v).  All samples were also analysed at a further dilution of 1 in15 with 
sample 9E additionally analysed at a further dilution of 1 in 60. This was to allow the intensity 
determined for highly contaminated samples to present within the calibration curve range. 
These further dilutions were carried out in 23.3% methanol to keep the final percentage of 
methanol comparable to the calibration curve.  
 
3.12. Matrix effects 
Microtitre plates were spotted as described in section 3.7. Antibodies for ZEA (ABZ 1/10,000), 
T2 (ABT-1 1/4000) and FUM (ABF-2 1/4000) were examined during the assay. Blank material 
for both maize and wheat were sourced by Queen’s University Belfast and were confirmed as 
blank for the analytes of interest by mass spectrometry. Six calibration curves were examined 
including PBS, methanol, maize spiked at the start of extraction, wheat spiked at the start of 
extraction, maize spiked at the end of extraction and wheat spiked at the end of extraction. 
 
3.13. Sample analysis 
Microtitre plates were spotted as described in section 3.7. Antibodies for ZEA (ABZ 1/10,000), 
T2 (ABT-1 1/4000) and FUM (ABF-2 1/4000) were examined during the assay. Maize and 
wheat samples (n=8) were extracted following the sample preparation method described in 
section 3.10. The sample concentrations for maize and wheat were determined from a 4 
parameter fit calibration curve using BIAevaluation version 4.1 software (Biacore, GE 
Healthcare). Results were compared to those obtained by analysing the same samples with 
Tecna screening test kits (Celer ZON v3, Celer T2 and Smart Strip FUMO) and HPLC/MS. 
Sample MA110 was a Reference Material whose FUM concentration was assessed by Test 
Veritas (Padova, I). 
 
4. Results and Discussion 
4.1. Optimisation 
In the optimisation of the ZEA assay it was noted that spot intensity was very low for the 
spotting concentration of 0.5 µg/ml with many spots not visible. Very little difference was 
observed in intensity between the four different spotting volumes (330, 670, 1000, 2000 pl) 
within each spotting concentration (0.5, 5 and 50 µg/ml). Nonetheless a spotting volume of 
1000 pl was selected as visually spots were easier to see for the alignment of grids.  
Additionally, intensity decreased as the alkaline phosphatase anti-rabbit IgG dilution increased 
to 1/20,000 with a dilution of 1/500 chosen for the assay. A spotting concentration for ZEA of 
50 µg/ml and an antibody dilution ZEA ABZ (1/10000) was therefore selected as this provided 
a suitable intensity and differential between negative and positive for the development of a 
calibration curve. For the optimisation of T2 and FUM parameters it was observed that spots 
were not visible for FUM antibody ABF-1 and T2 antibodies ABT-1 and ABT-2 at the spotting 
concentration of 10 µg/ml. Very little difference in spot intensity was observed between 50, 
100 and 200 µg/ml spotting concentrations for T2 and FUM. As the spotting concentration 
increased the sensitivity of the assay decreased and a higher antibody dilution was required. 
However, at the highest antibody dilutions the spots were barely visible with quite low spot 
intensities obtained. A spotting concentration of 50 µg/ml was therefore selected for T2 and 
FUM with antibody dilutions 1/4000 for both ABT-1/ABT-2 and ABF-1/ABF-2 antibodies as 
these conditions provided suitable intensity and differential between negative and positive to 
allow further assay development. 
 
4.2. Individual calibration curves 
Individual calibration curves, in a nine spot format (3x3 array), for ZEA (ABZ antibody), T2 
(ABT-1 and ABT-2 antibodies) and FUM (ABF-1 and ABF-2 antibodies) using both PBS and 
methanol were examined. For T2 and FUM antibodies ABT-1 and ABF-2 were selected for 
the final multiplex assay as illustrated in Figures 1 and 2. The average spot intensity of the nine 
spots per well was calculated and the average of the two wells was determined. The spot 
intensity for ZEA was approximately 2000 pixels (0 ppb) and sensitivity of the assay (based 
on the 50 % inhibition concentrations) decreased from 21.9 ppb to 100.2 ppb between PBS and 
methanol calibration curves (Table 1). Since mycotoxins such as ZEA tend to be lipophilic and 
organic solvents are often used to extract analytes from samples for immunoassays it is 
necessary to use a water miscible organic solvent in the assay buffer for ELISAs. Methanol 
tends to be the most widely used. However, it has been shown that with increased methanol 
concentration the sensitivity of the assay can decrease [37]. The methanol may affect either the 
immobilised protein conjugate or the antibody protein structure causing reduced binding to the 
ZEA due to interference and thereby decreasing the sensitivity. For T2 the spot intensity for 
both antibodies was very low at approximately 800 – 1000 pixels (0 ppb) whereby grids had to 
be manually aligned. Sensitivity for both the ABT-1 and ABT-2 antibodies were very similar 
based on the 50 % inhibition concentrations (1 ppb) and remained similar between PBS and 
methanol calibration curves (Table 1). The ABT-1 antibody was selected for the multiplex 
calibration curve as the intensity was slightly higher and whereby automatic grid alignment 
could be achieved to determine signal intensity. For FUM the starting intensity (0 ppb) for the 
ABF-2 antibody was slightly higher at approximately 2000 pixels compared to the ABF-1 
antibody (1500 pixels). Sensitivity for both the ABF-1 and ABF-2 antibodies were very similar 
based on the 50 % inhibition concentrations; however, sensitivity did decrease from 
approximately 60 ppb to 100 ppb between PBS and methanol calibration curves (Table 1). 
Again, the methanol may affect the FUM antibody and cause some interference in binding to 
FUM decreasing the sensitivity. The ABF-2 antibody was selected as the antibody to use for 
the multiplex calibration curve because the intensity was much higher. Reduced sensitivities 
for the methanol calibration curves was possibly because methanol will cause reduced antibody 
binding due to the target due to solvent effects on the antibody. However, for these mycotoxins 
due to their solubility properties it is necessary to use an extraction solvent in the sample 
preparation methods. 
 
4.3. Multiplex calibration curves 
Multiplex calibration curves, in a 12 spot format (4x3 array), for ZEA (ABZ antibody), T2 
(ABT-1 antibody) and FUM (ABF-2 antibody) using both PBS (Figure 1) and methanol (Figure 
2) over six wells and over three days are illustrated. Variation in the average intensity of the 
four spots per well was 18.8, 20.5 and 12.7 % for the PBS calibration curve and 18.5, 20.1 and 
12.4 for the methanol calibration curve for ZEA, T2 and FUM respectively. This was 
determined as the average % CV of all standards in the calibration curve over 6 wells and 3 
days. Improved curve shapes were produced for T2 as multiplex calibration curves with only a 
slight difference between PBS and methanol. Spot intensity for T2 was very low therefore the 
grid alignment had to be completed manually. Calibration curves for FUM were similar 
between PBS and methanol until the final two standards. It is, however, more difficult to align 
the grids when the spot intensity is faint and so this may account for this difference. Sensitivity, 
assessed by examining the 50 % inhibition concentration of the assay, for the nanoarray for 
ZEA, T2 and FUM are presented in Table 1. Sensitivity decreased for ZEA in PBS from 21.9 
ppb (individual) to 70.1 ppb (multiplex) and similarly for methanol from 100.2 ppb (individual) 
to 172.4 ppb (multiplex). The standard deviation of the intensity of each spot is greater in the 
multiplex assay for ZEA indicating that there may be interference occurring from the other 
assays. Sensitivity decreased for T2 in PBS from 1.0 ppb (individual) to 2.8 ppb (multiplex) 
and similarly for methanol from 0.9 ppb (individual) to 3.2 ppb (multiplex). Similar to ZEA 
the standard deviation of the intensity of each spot is greater in the multiplex assay for T2 
indicating that there may be interference occurring from the other assays. Finally, sensitivity 
also decreased for FUM in PBS from 63.9 ppb (individual) to 90.9 ppb (multiplex) and 
similarly for methanol from 105.0 ppb (individual) to 129.3 ppb (multiplex). Reduced 
sensitivities between the individual and multiplex calibration curves is possibly due to 
interference and non-specific binding of reagents between the assays. As the standard deviation 
of the spots increased more significantly in the ZEA and T2 assays when multiplexed compared 
to the FUM assay the reagents in these assays may be interacting. Multiplexing assays with 
different antibodies may lead to some degree of interference between antibodies and between 
targets even due to steric hindrance. Nonetheless, certain benefits of multiplexing outweigh the 
loss of sensitivity in most applications. 
 
4.4. Cross reactivity 
For the multiplex nanoarray the characterisation of the antibodies, especially in regard to their 
cross reactivity is important to know. The cross reactivity profile for each antibody was 
examined by analysing individual calibration curves prepared in methanol for ZEA, T2, HT2, 
FUM B1, FUM B2, FUM B3 and DON as illustrated in Figure 3. The results demonstrated that 
the T2 antibody ABT-1 showed 74 % cross reactivity to HT2. FUM antibody ABF-2 showed 
48 % and 24 % cross reactivity to FUM B2 and FUM B3 respectively. Moreover, the antibodies 
used turned out to be specific for their corresponding mycotoxin and showed minimal to no 
cross reactivity for the concentrations used in the assay for the other mycotoxins (Figure 3). 
 
4.5. Intra and inter spotting precision  
The data for the spotting precision of each mycotoxin was examined by analysing a 0 pbb 
standard in all 96 wells of a three-plex (ZEA, T2 and FUM) spotted system using both PBS 
and methanol. Results are shown in Table 2. Intra-spotting precision was 6, 11 and 10 % for 
PBS and 5, 11 and 12 % for methanol for ZEA, T2 and FUM respectively. Inter-spotting 
precision was 4, 14 and 6 % for PBS and 3, 9 and 16 % for methanol for ZEA, T2 and FUM 
respectively over 3 spotting days. 
 
4.6. Sample preparation 
Both maize and wheat were extracted according to the protocol described in section 3.11. All 
extracts were diluted 1 in 3 and 1 in 15 to give a final dilution of 15 and 75 and a percentage 
of methanol at 23.3 %. Sample 9E was highly contaminated for T2 and FUM and therefore the 
extract was diluted 1 in 60 to give a final dilution of 300 so that the response would present 
within the calibration range. Taking into account the 50 % inhibition concentration and the 1 
in 3 extraction dilution this converts to 1050.9, 42.0 and 1364.1 µg/kg for ZEA, T2 and FUM 
respectively which meets the regulatory limits for these mycotoxins in feed. It was observed 
that for wheat samples using only a 1 in 3 dilution produced a white cloudy extract. There is 
some component of the wheat that is causing a cloudy supernatant which is not present in the 
maize. It may therefore be better to increase the dilution to 1 in 15 for the assay (final dilution 
75). This would dilute out the extract and minimize the cloudy extract interfering with the test. 
 
4.7. Matrix effects 
The calibration curves were assessed for ZEA (ABZ antibody), T2 (ABT-1 antibody) and FUM 
(ABF-2 antibody) for matrix effects in maize (Figure 4) and wheat (Figure 5). . For ZEA the 
intensity for the 0 ppb standard for maize and wheat were very similar to the PBS and methanol 
curves. However, the difference in the curve shape was more pronounced for the maize and 
wheat. Sensitivity for ZEA in matrix is somewhat reduced for both maize and wheat (Table 1). 
For T2 the intensity for the 0 ppb standard for maize and wheat was approximately 16 % and 
13 % lower than the PBS and methanol curves respectively. The calibration curves for maize 
showed a large drop between the first two standards giving a poor curve shape. In comparison, 
the wheat produced a better curve shape and compared better with the PBS and methanol 
curves. Sensitivity for T2 for both maize and wheat is reduced when spiked at the start of the 
extraction, however, is similar to PBS and methanol curves when spiked at the end into 
negative extract (Table 1). For FUM the intensity for the 0 ppb standard for maize was 
approximately 11 % lower than the PBS and methanol curves with wheat showing an intensity 
approximately 7 % higher in comparison. The calibration curve for the maize spiked at the end 
of the extraction showed a slightly different curve shape compared to the others. Sensitivity for 
FUM in matrix is somewhat reduced for both maize and wheat (Table 1). A differential in the 
calibration curves prepared pre and post extraction illustrates the extent of the recovery of the 
assay.  It was evident that due to substantial differences between these two curves that recovery 
was not 100% and whereby some mycotoxins may not be extracted during the extraction 
process. This would mean that the concentration of unknown samples should be determined 
from a calibration curve prepared pre-extraction during the final validation of the assay or the 
extraction procedure should be examined further to help improve the recovery of the assay. 
 
4.8. Sample analysis 
 The analysis of the wheat and maize samples (n=8) using the multiplex nanoarray in 
comparison with other screening methods and HPLC are presented in Table 3. Comparing the 
nanoarray results to concentrations for ELISA, LFD and HPLC/MS it was observed that for 
ZEA there were five samples that correlate in terms of negative and positive results. Samples 
L2 and GT were both expected to be < 50 ppb but have a higher concentration when analysed 
by the mycotoxin nanoarray at 132 ppb and 206 ppb respectively. Additionally, sample MA110 
had a higher concentration when analysed by the mycotoxin nanoarray. For the ZEA assay only 
ZEA was determined whereby for future work other analogues of ZEA should be examined to 
ensure differences between the assays are not due to the cross-reactivity towards these 
analogues. For T2 there were six samples that correlate in terms of negative and positive results. 
Sample GT was expected to be < 5 ppb but had a higher concentration of 86 ppb when analysed 
by the mycotoxin nanoarray. Additionally, sample MA110 had a higher concentration when 
analysed by the mycotoxin nanoarray. Finally, for FUM there were seven samples that match 
up in terms of negative and positive results. The reference material MA110 had a higher 
concentration of 116 ppb when analysed by the mycotoxin nanoarray compared to the certified 
concentration of < 50 ppb. Differences detected for certain samples may be due to the non-
homogeneity of the sample as it is well known that mycotoxins are very heterogeneous in 
nature [38], sensitivities of the different testing platforms and possible variations in cross 
reactivity profiles of the antibodies used to analogues of the compounds in the screening tests 
as analysed in different laboratories at different times. The sample for analysis provided for the 
nanoarray study was relatively small and in this study the analysis by the different methods 
was performed over different sites and whereby the sample may have been stored under 
different conditions. The differences detected for certain samples may also be due to the 
heterogeneity in distribution of the mycotoxin in the sample provided to the different sites. It 
is well established that mycotoxin distribution in a sample can be very heterogeneous in nature 
and storage conditions are important. This paper is a proof of concept and feasibility study to 
show that the mycotoxin nanoarray application is highly feasible. Further work would include 
a single laboratory validation and substantive survey of real samples in direct analytical 
comparison with other routine testing platforms.  
 
4.9 Image and Data Analysis  
For the implementation of the nanoarray application the reader must be employed that can 
record the spot intensity at the spatially defined zones compared to the whole well as in current 
laboratory ELISA applications. For novice end users a current major drawback of the reader 
technology is the time required for image analysis and data processing. Currently all 96 wells 
are imaged and each image must be opened by the software for grid alignment and calculation 
of spot intensity. Aligning grids for one microtitre plate takes approximately 2 hr, generating 
96 excel sheets. Further data processing can take a further 1 hr therefore data processing per 
plate can take up to 3 hr. This is not applicable from a commercial point and unless data 
processing software solutions can be addressed it would be unsuitable for commercial and 
routine laboratory use. Reference spots should be assessed and included in future work which 
may help with grid alignment. For this to be a viable method the reader software needs to be 
enhanced for automated data processing for all 96 wells generating calibration curves and 
interpolating unknown samples to these curves. Additionally, another drawback is that any dust 
or particles present in the well can interfere with the image and spot intensity especially if it is 
covering a spot within the nanoarray. Therefore, clean room facilities for production and use 
may need to be a consideration. 
 
5. Conclusions 
Monitoring programmes for mycotoxins have become a necessity because of the potential 
consequences to human and animal health. New innovations in technology applications to 
improve surveillance for the industry are essential. A sensitive and novel multiplex nanoarray 
has been developed allowing for the semi-quantitative and simultaneous screening of three 
regulated mycotoxins. The immunological format offers a high throughput detection method 
for ZEA, T2 and FUM, whereby with improved software utilities on the reader results, results 
would be available in around 70 min. The benefit to this system is that it follows established 
ELISA protocols whereby laboratories with immunological screening methods already in place 
have end users familiar to the steps in analysis and comparable to LFD offers a higher 
throughput of samples. The simplicity, sensitivity and comparative labour to ELISA of the 
mycotoxin nanoarray assay means it could be used as a screening method in a monitoring 
environment for the presence of these harmful mycotoxins in food. This technology 
demonstrates the potential feasibility for an easy to use and sensitive multiplex mycotoxin 
detection method. This study has shown some very promising data and required considerations 
that are worthy of further research to determine the nanoarray suitability for a commercial 
diagnostic test. Prior to implementation a full validation and inter-laboratory trial of the 
nanoarray should be conducted following accreditation guidelines for screening methods. 
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Table 1: Sensitivity of the mycotoxin nanoarray for ZEA, T2 and FUM as both individual and 
multiplex curves in PBS, 23.3 % methanol and extract (maize and wheat) based on 50 % 
inhibition concentrations. 
Mycotoxin System Antibody Matrix n 
50 % Inhibition 
(ppb) 
ZEA 
Individual ABZ PBS 2 21.9 
Individual ABZ 23.3 % methanol 2 100.2 
Multiplex ABZ PBS 20 70.1 
Multiplex ABZ 23.3 % methanol 20 172.4 
Multiplex ABZ Wheat spiked at start 2 299.6 
Multiplex ABZ Wheat spiked at end 2 197.4 
Multiplex ABZ Maize spiked at start 2 > 500 
Multiplex ABZ Maize spiked at end 2 43.6 
T2 
Individual ABT-1 PBS 2 1.1 
Individual ABT-1 23.3 % methanol 2 1.7 
Individual ABT-2 PBS 2 1.0 
Individual ABT-2 23.3 % methanol 2 0.9 
Multiplex ABT-1 PBS 20 2.8 
Multiplex ABT-1 23.3 % methanol 20 3.2 
Multiplex ABT-1 Wheat spiked at start 2 6.0 
Multiplex ABT-1 Wheat spiked at end 2 0.7 
Multiplex ABT-1 Maize spiked at start 2 2.9 
Multiplex ABT-1 Maize spiked at end 2 0.5 
FUM 
Individual ABF-1 PBS 2 61.5 
Individual ABF-1 23.3 % methanol 2 110.0 
Individual ABF-2 PBS 2 63.9 
Individual ABF-2 23.3 % methanol 2 105.0 
Multiplex ABF-2 PBS 20 90.9 
Multiplex ABF-2 23.3 % methanol 20 129.3 
Multiplex ABF-2 Wheat spiked at start 2 369.7 
Multiplex ABF-2 Wheat spiked at end 2 216.7 
Multiplex ABF-2 Maize spiked at start 2 141.7 
Multiplex ABF-2 Maize spiked at end 2 25.9 
 
 
Table 2: Intra and inter assay precision for the multiplex mycotoxin nanoarray for both PBS 
and 23.3 % methanol. 
Mycotoxin Matrix 
Intra Assay Precision (% CV) Inter Assay 
Precision  
(% CV) 
(n=3) 
Day 1 
(n=96) 
Day 2 
(n=96) 
Day 3 
(n=96) 
Average 
(n=3) 
ZEA PBS 6 5 6 6 4 
23.3 % methanol 5 6 5 5 3 
T2 PBS 15 7 11 11 14 
23.3 % methanol 9 14 10 11 9 
FUM PBS 9 8 13 10 6 
23.3 % methanol 8 18 9 12 16 
 Table 3: Mycotoxin concentrations for maize (n=5) and wheat (n=3) samples expressed as ppb. Samples were analysed by the multiplex mycotoxin 
nanoarray and compared to screening (ELISA and LFD) and HPLC/MS results for these mycotoxins.   
Sample 
No. 
Sample        
Type 
Sample     
Code 
ZEA Concentration (ppb) T2 Concentration (ppb) FUM Concentration (ppb) 
ELISAa HPLC 
Mycotoxin 
Nanoarray 
ELISAb HPLC 
Mycotoxin 
Nanoarray 
LFDc HPLC 
Mycotoxin 
Nanoarray 
1 Maize 9E 277 325 210 650 787 487 - 37,100 41,756 
2 Maize AZF < 25 < 50 17 < 25 - 0 < 150 < 100 0 
3 Maize L2 < 25 - 132 < 25 < 25 5 - 3554 1536 
4 Maize GR2 55 56 217 < 25 < 25 11 5361 - 2376 
5 Maize MA110* < 25 < 50 178 - < 25 50 < 150 < 50* 116 
6 Wheat WH43 223 - 197 133 101 111 2186 - 2249 
7 Wheat FR2 < 25 <5 22 < 25 - 23 - 111 274 
8 Wheat GT < 25 < 10 206 - < 5 86 - 97 299 
       
 
           a Tecna Celer ZON v3 
      b Tecna Celer T2 
     c Tecna Smart Strip FUMO 
     *Test Veritas (I) Reference Material for fumonisins. Assigned value according to the Certificate of the Provider 
     - No result available 
 
Figure 1: Individual and multiplex calibration curves in PBS buffer for ZEA (a), T2 (b) and 
FUM (c) using the mycotoxin nanoarray (Individual curves: n=2 analysis, 9 spots per 
analysis; Multiplex curves: n=6 analysis, 4 spots per analysis, x 3 spotting days). 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Individual and multiplex calibration curves in 23.3% methanol for ZEA (a), T2 (b) 
and FUM (c) using the mycotoxin nanoarray (Individual curves: n=2 analysis, 9 spots per 
analysis; Multiplex curves: n=6 analysis, 4 spots per analysis, x 3 spotting days). 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Cross reactivity for ZEA (a), T2 (b) and FUM (c) using the multiplex mycotoxin 
nanoarray (n=2 analysis, 4 spots per analysis). 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4: Matrix effects for maize for ZEA (a), T2 (b) and FUM (c) using the multiplex 
mycotoxin nanoarray (n=2 analysis, 4 spots per anaysis). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Matrix effects for wheat for ZEA (a), T2 (b) and FUM (c) using the multiplex 
mycotoxin nanoarray (n=2 analysis, 4 spots per anaysis). 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
